Opus Genetics (IRD) PT Lowered to $9 at RBC Capital
Tweet
Share
E-mailGet Alerts IRD Hot Sheet
Price: $3.83 +5.80%
Rating Summary:
17 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 18
Rating Summary:
17 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 18
Join SI Premium – FREE
RBC Capital analyst Lisa Walter lowered the price target on Opus Genetics (NASDAQ: IRD) to $9.00 (from $10.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Yamazaki Baking (2212:JP) PT Lowered to JPY4,100 at UBS
- Partners Group Holding AG (PGHN:SW) (PGPHF) PT Raised to CHF930 at Barclays
- BNP Paribas Exane Downgrades Reckitt Benckiser (RKT:LN) (RBGLY) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
